EXPD
43
-4
CA
22
-3
ABT
59
2
PYPL
52
-2
MRK
17
-5
ADP
65
-3
KMX
61
-3
VRSN
53
-5
WMB
68
2
DG
8
-2
MNST
45
-21
NSC
53
-4
SPG
60
2
ORLY
60
-5
MMM
35
-5
WBA
43
-4
KR
36
-6
TRIP
50
-4
DLTR
38
-4
IR
63
-3
EXPD
43
-4
CA
22
-3
ABT
59
2
PYPL
52
-2
MRK
17
-5
ADP
65
-3
KMX
61
-3
VRSN
53
-5
WMB
68
2
DG
8
-2
MNST
45
-21
NSC
53
-4
SPG
60
2
ORLY
60
-5
MMM
35
-5
WBA
43
-4
KR
36
-6
TRIP
50
-4
DLTR
38
-4
IR
63
-3
Financhill
Back

Intellia Therapeutics Vs. Repligen Industry Stock Comparison

Sell
18

NTLA
Intellia Therapeutics

Last Price:
13.96
Seasonality Move:
12.78%
Sell
30

RGEN
Repligen

Last Price:
124.90
Seasonality Move:
7.3%
Sell
18
Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics a Buy, Sell or Hold?

  • The current Intellia Therapeutics [NTLA] share price is $13.97. The Score for NTLA is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Repligen (RGEN) is a Sell

Is Repligen a Buy, Sell or Hold?

  • The current Repligen [RGEN] share price is $124.73. The Score for RGEN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NTLA Stock Price Chart

What is Intellia Therapeutics's stock price today?

  • The Intellia Therapeutics share price today is $13.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing selling pressure, which indicates risk of future bearish movement.

RGEN Stock Price Chart

What is Repligen's stock price today?

  • The Repligen share price today is $124.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGEN is experiencing selling pressure, which indicates risk of future bearish movement.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.97 Sell
Relative Strength Index (14 RSI): 33.58 Sell
Chaikin Money Flow: -3585168 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.75 - 19.35) Sell
Bollinger Bands (100): (17.79 - 24.51) Sell

RGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.46 Sell
Relative Strength Index (14 RSI): 36.22 Sell
Chaikin Money Flow: -1285419 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (134.94 - 146.38) Sell
Bollinger Bands (100): (130 - 153.64) Sell

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.02 Sell
20-day SMA: 16.35 Sell
50-day SMA: 18.61 Sell
200-day SMA: 23.37 Sell
8-day EMA: 15.6 Sell
20-day EMA: 16.42 Sell
50-day EMA: 18.28 Sell
200-day EMA: 23.32 Sell

RGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 142.02 Sell
20-day SMA: 140.23 Sell
50-day SMA: 141.19 Sell
200-day SMA: 157.58 Sell
8-day EMA: 139.7 Sell
20-day EMA: 140.54 Sell
50-day EMA: 141.71 Sell
200-day EMA: 151.3 Sell

Intellia Therapeutics Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.16 per share.

Repligen Earnings Growth & RGEN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.22 per share.

Intellia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Repligen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):